Atherosclerosis

Article	Citations
TNF-α/STEARATE INDUCED H3K9/18 HISTONE ACETYLATION AMPLIFIES IL-6 EXPRESSION IN ADIPOCYTES	148
THE MOLECULAR BASIS OF DIFFERENT GENETIC LIPID DISORDERS IN LEBANON	125
IMPACT OF CALEBIN-A ON KEY DIABETES-ASSOCIATED GENES	106
CARDIOVASCULAR MORBIDITYAMONG TUBERCULOSIS PATIENTS IN INDIA: A CROSS-SECTIONAL STUDY	106
ROLE OF PATIENT ADVOCATES IN SECURING APHERESIS ACCESS IN LEBANON	105
Inclisiran as monotherapy compared with placebo or ezetimibe in patients at low to borderline atherosclerotic cardiovascular disease risk: Results from the VICTORION-Mono randomized clinical trial	94
Integrative prediction models of gestational diabetes mellitus: Insights from lipidomic profiling	94
Quantitative data comparing LDL results produced by lipid ultracentrifugation with those calculated by the Sampson equation	88
Antibody functionalized lipoprotein complexes (LPC) including a repolarizing drug for the targeted therapy of atherosclerosis	84
The effect of PCSK9 inhibitor treatment on plasma proteome in patients with and without familial hypercholesterolemia	76
Browning of perivascular adipose tissue during early atherosclerosis progression: A contrast to clinical atherosclerosis	76
Low residence time of exogeneous HDL is associated with preserved renal function in rats treated with HgCl2 and accumulation of HDL-protein in adipose tissue	76
Modulating atherosclerotic plaque formation by targeting the plasminogen receptor Plg-RKT	73
Lp(a) levels in individuals with metabolic-dysfunction associated steatotic liver disease	73
Sex-specific impact of the COVID-19 pandemic on metabolic syndrome prevalence	73
18FDG-pet imaging reveals glycolytic activity as a marker of atherosclerotic disease activity	72
Levels of C5B-9, RGC-32 and SIRT1 in chronic and acute ischemic coronary artery disease	70
Rates of atherosclerotic cardiovascular events and their management in a longitudinal cohort of dermatomyositis patients with skin involvement	65
Association of traditional cardiometabolic risk factors with atherosclerotic cardiovascular disease in familial hypercholesterolaemia individuals with severe elevation of LDL-cholesterol	65
Activated and regulatory T-helpers and blood monocytes in patients with HFPEF and type 2 diabetes mellitus	64
Anti-endoglin monoclonal antibody inhibits the progression of liver sinusoidal endothelial inflammation and fibrosis in metabolic dysfunction-associated steatohepatitis	63
Noninvasive parameters of myocardial work and diastolic myocardial function in the assessment of heart failure with preserved ejection fraction in patients with postinfarction cardiosclerosis	60
Clinical phenotypes of patients with stable coronary artery disease, with or without concomitant COVID-19, based on left ventricular function and cerebral blood flow	56
Doxorubicin promotes atherosclerosis in an apolipoprotein e-deficient mouse model, potentially associated with serpina3n	54
LATENT TB PREVALENCE AMONG DIABETICS: A SYSTEMATIC REVIEW AND META-ANALYSIS	52

ELEVEN YEARS FOLLOW-UP OF 1351 YOUNG FH-INDIVIDUALS IN NORWAY	52
CLINICAL AND GENETIC CHARACTERISTICS OF LATE-ONSET LAL DEFICIENCY IN OMAN	51
COMMUNITY ENGAGEMENT STRATEGY: ENHANCING VACCINE COVERAGE FOR CARDIOMETABOLIC DISEASE CONTROL	51
Corrigendum to “The correlation between medial pattern of intracranial arterial calcification and white matter hyperintensities” [Atherosclerosis 381 (2023) 117247]	50
Statin use is associated with less ST-elevation versus non-ST-elevation myocardial infarction in a nationwide study	49
Rabies vaccine induced microangiopathy	46
Low stenosis low volume carotid artery atherosclerotic plaque for early HI-LLT prescription in first grade cardiovascular prevention	46
Differences in coronary angiographic findings and outcomes between men and postmenopausal women with chest pain	44
Vascular structural changes in diabetes mellitus patients with chronic kidney disease	43
Circulating large extracellular vesicles from STEMI patients contribute to cardiovascular damage	43
Illness perception in patients with familial hypercholesterolemia	42
Association between level of depression and coronary heart disease, stroke risk and all-cause and cardiovascular mortality	41
Bempedoic acid efficacy and safety in 7,597 non-diabetic patients, with and without metabolic syndrome, from the randomized, placebo-controlled clear outcomes trial	38
“Early detection of cardiovascular risk factors in women following gestational diabetes mellitus: A cohort study”	38
Compensatory metabolic responses in ChREBP-deficient brown adipose tissue	38
Severe hypertriglyceridemia and its correlation with clinical atherosclerosis and pancreatitis investigated in beta-quantification	38
Statin treatment reduces long-term risk of revision surgery following total hip arthroplasty in osteoarthritis patients: A registry-based study	36
The effect of MMP 9, TIMP-1 on the dynamics of cardiac fibrosis in patients with and without coronary artery disease 2 years after renal denervation	36
miR-148a-3p: A novel therapeutic candidate modulating angiogenesis and senescence for enhanced myocardial infarction recovery – experimental insights and targets explored	36
Residual risk in coronary artery disease: Insights from an observational study	36
Machine-learning-based models to predict atherogenic index of plasma range using oculomics and clinic variables in KNHANES for assessing the risk of cardiovascular disease	35
Circulating monocyte phenotype: A novel biomarker of atherosclerosis	34
Dissecting sexual dimorphism in aortic valve stenosis by proteomics	34
Risk factors for progressive cardiorenal syndrome in patients with chronic kidney disease: The CRIC study	33
The comparative analyses of combined medicine alpha-lipoic acid and zinc with statins in the treatment of dyslipidemia in patients with atherosclerosis	33
Rare variants in U2-spliceosome genes are involved in autosomal dominant hypercholesterolemia	33
Comorbidities, frailty, and prognosis in elderly patients with atrial fibrillation and ischemic heart disease: Insights from a tertiary hospital cohort study	33
Sex differences in the treatment of familial hypercholesterolemia: A systematic review and meta-analysis	33
Bivariate relation of vascular health and blood pressure progression during childhood	32
Ethnic variations in neutrophil count as predictors of prognosis following acute myocardial infarction	32
Sex differences in LDL-C control in a primary care population: The PORTRAIT-DYS study	31
Soluble CD40 receptor is a biomarker of the burden of carotid artery atherosclerosis in subjects at high cardiovascular risk	31
Heightened splenic and bone marrow uptake of 18F-FDG PET/CT is associated with systemic inflammation and subclinical atherosclerosis by CCTA in psoriasis: An observational study	31
Interplay between epigenetic mechanisms and transcription factors in atherosclerosis	30
Effect of biological sex on human circulating lipidome: An overview of the literature	30
The effect of LPA Thr3888Pro on lipoprotein(a) and coronary artery disease is modified by the LPA KIV-2 variant 4925G>A	30
Transcriptome analysis revealed a two-step transformation of vascular smooth muscle cells to macrophage-like cells	30
Illuminating the full spectrum of APOE variation	29
Antagonism of miR-148a attenuates the progression of atherosclerosis in APOBTGApobec-/-Ldlr+/- mice	29
Effect of APOC3 inhibition with volanesorsen on hepatic steatosis in patients with severe hypertriglyceridemia	29
Circular decoys sponge miR-21 and miR-146a in senescent vascular cells	29
IL-21R blockade reduces atherosclerosis development	29
Hepatic Cdkal1 deletion regulates HDL catabolism and promotes reverse cholesterol transport	29
Genetic risk score for human serum lipidome and its association with angiographic coronary artery disease	29
Association of genetically predicted levels of circulating blood lipids with coronary artery disease incidence	29
Possible clinical usefulness of polygenic risk scores among patients with established atherosclerotic cardiovascular disease	28
Methotrexate associated with a lipid core nanoparticle prevented the dilation and dissection of the aortic arch in mice with Marfan syndrome	28
Regulation of interleukin 1Β drives endothelial-to-mesenchymal transition of valve endothelial cells in patients with aortic valve sclerosis	28
The role of systemic inflammation in reducing the elasticity of the main arteries in patients with chronic heart failure in combination with obesity	28
Effect of high- intensity extremely low frequency magnetic field on the intermediate stage atherosclerotic plaque remodeling: Monitored by histopathology and color doppler ultrasonography	28

Comparison of cardiovascular prognosis between triglyceride variability and exposure estimate in diabetic patients	28
Silencing of PCSK9 by SIRNA-functionalized RHDL as tool to upregulate LDLR expression in hepatocytes	28
Size, fatty acid and protein characterization of different populations of extracellular vesicles obtained by sequential centrifugation. An useful tool to dissect their biological properties?	27
Influence of low glycemic index diet on inflammatory state and lipid parameters in patients with atherosclerotic coronary artery disease	26
Laser- mediated thermal angioplasty of occluded artery accompanied by disulphonated aluminum phthalocyanine - mediated photodynamic therapy combined with catheter- based ruthenium-106 brachytherapy	26
TREM2 macrophages in adipose tissue and cardiovascular risk	26
An upregulation of scube 2 expression in type 2 diabetes mellitus with dyslipidemia	25
Age- and gender-specific lipid and lipoprotein levels and percentiles from the Thai National Health Examination Survey (NHES-VI) in Thailand	25
Quality of life in older patients with obesity and chronic kidney disease	25
Lipid profile assessment as a factor of diabetic nephropathy progression	25
Targeted proteomics and the presence of carotid plaques in subjects at low cardiovascular disease risk	25
Atherosclerosis in Brazil: An ecological study	25
Statin therapy and lipoprotein(a) levels: A systematic review and meta-analysis	24
The reliability of coronary artery calcium score in symptomatic patients: Questioning the “power of zero”	24
Assessment of the improvement in perfusion after endovascular intervention by hyperspectral imaging	24
Reversing the functional- and regenerative capacity of senescent endothelial cells by pharmacological reprogramming	24
Do triglycerides have an influence on endothelial function detected by Laser Doppler flowmetry?	24
Management of significantly elevated lipoprotein(a) in patients without established ASCVD	23
Does the lipoprotein(A) genotype influence the diagnosis of familial hypercholesterolemia?	23
Carotid ultrasound and coronary calcium for the prediction of incident cardiac disease in asymptomatic individuals: A further step towards precision medicine especially in women?	23
Influence of mineral bone disease biomarkers in carotid modeling as a marker of early atherosclerosis in dialysis patients	23
Global Familial Hypercholesterolaemia Studies Collaboration (FHSC)	23
Genome-wide association study on HDL-mediated cholesterol efflux capacity	23
Bioactive lipids and lipoprotein lipase in epicardial adipose tissue from patients with coronary artery disease: Unfolding a missing link	23
Effect of B-mode ultrasound- guided extracorporeal low- level focused sonotherapy on early stage atherosclerosis regression using color doppler ultrasonography and histopathology	22
The impact of cholesterol lowering drugs on metabolism and epigenetics	22
Vulnerable atheromatous plaque stabilization using extracorporeal shock wave- mediated sonoporation therapy- assisted HDL and atorvastatin combination therapy	22
The real experience of reaching an extremely low LDL-C level in high risk patients	22
Associations of the fatty acids with the concentration of antioxidant enzymes in the blood in men with coronary heart disease	22
Sex differences of lipoprotein(a) levels and associated risk of morbidity and mortality by age: The Copenhagen general population study	22
Aging accelerates atherosclerosis development in C57BL/6 mice upon PCSK9 overexpression	21
Collaboration of clinic and Biobank as an effective model for dyslipidemia research	21
Endothelial ACKR3 drives atherosclerosis by promoting immune cell adhesion to vascular endothelium	20
Evolocumab treatment in paediatric patients with homozygous familial hypercholesterolemia: Data from three pooled open-label studies	20
Tetrahydroxystilbene glycoside attenuates endothelial dysfunction and obesity-associated hypertension in obese rats: The role of omentin-1	20
Editorial board	20
Coronary computed tomography angiography-derived endothelial shear stress in myocardial bridging	20
Common perinatal characteristics and adverse obstetric complications leading to overweight in adolescence: Assessment of independent and shared maternal-offspring pathways	20
Caspase 8-dependent inhibition of necroptosis prevents plaque necrotic core formation	20
Genetic expression and immunofluorescence mapping of NaV1 highlight potential therapeutic targets in anti-inflammatory treatment of aortic valves stenosis	20
Sociodemographic determinants of change in cardiovascular health in middle adulthood in a bi-racial cohort	19
The value of a negative study	19
Coronary artery calcium: The canary in the coal mine	19
Isolation and culture of murine aortic cells and RNA isolation of aortic intima and media: Rapid and optimized approaches for atherosclerosis research	19
Impact of the clinical diagnostic strata of familial hypercholesterolemia on risk stratification among patients with hypercholesterolemia	19
The long journey of lipoprotein(a) from cardiovascular curiosity to therapeutic target	19
Fgf23 expression increases atherosclerotic plaque burden in male ApoE deficient mice	19
Editorial Board	19
Galectin-9: A novel promoter of atherosclerosis progression	18
Obesity is associated with coronary artery stenosis independently of metabolic risk factors: The population-based SCAPIS study	18
Gene set analysis of transcriptomics data identifies new biological processes associated with early markers of atherosclerosis but not with those of osteoporosis: Atherosclerosis-osteoporosis co/multi	18
Course of the effects of LDL-cholesterol reduction on cardiovascular risk over time: A meta-analysis of 60 randomized controlled trials	18
Repeated measurement of lipoprotein(a): technical versus biological variability	18
Association of thyroid peroxidase antibody with the RNF213 p.R4810K variant in ischemic stroke/transient ischemic attack	18
Relationship between stress hyperglycemia and worsening heart failure in patients with significant secondary mitral regurgitation	18
N-acetylcysteine therapy reduces major adverse cardiovascular events in patients with type 2 diabetes mellitus	18
The impact of gene variants on the thickness and softness of the Achilles tendon in familial hypercholesterolemia	18
Editorial Board	17
Role of fatty acids in the pathogenesis of ß-cell failure and Type-2 diabetes	17
METABOLOMIC ANALYSIS OF KAZAKH PATIENTS WITH METABOLIC SYNDROME BY GC/MS	17
LAUNCHOF THE FIRSTHOFH AWARENESS DAY: ADDRESSING UNMET NEEDS	17
ACCURACY OF TROPONIN VALUE IN ELDERLY WITH ACUTE CORONARY SYNDROME	17
COMPUTATIONAL IDENTIFICATION OF SMALL MOLECULES FOR MODULATING ATHEROSCLEROSIS AND NAFLD	17
Lipotoxicity-driven metabolic dysfunction-associated steatotic liver disease (MASLD)	17
ESTABLISHMENT OF ELISA SYSTEM FOR MODIFIED LDLADIPONECTIN COMPLEX	17
FIRST TIME USE OF LOMITAPIDE IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA, UAE	17
Editorial board	16
CARDIO-PROTECTIVE ROLE OF ROSMARINIC ACID ON ISOPRENALINE INDUCED CARDIAC DYSFUNCTION	16
Clinical profile of familial hypercholesterolemia phenotype in adults attended in primary care in a large healthcare area	16
Effect of lipid-lowering therapies on lipoprotein(a) levels: a comprehensive meta-analysis of randomized controlled trials	16
Minigene splicing reporter assay: a high-stake tool for genetic diagnosis in familial hypobetalipoproteinemia	16
Different plasma biomarker patterns associated with coronary atherosclerosis in low- versus high-risk individuals – an observational cross-sectional study	16
Lipoprotein(a) and cardiovascular disease: Make use of the knowledge we have	16
GENETIC AND BIOCHEMICAL ANALYSIS OF FOUR JAPANESE SEVERE HYPERTRIGLYCERIDEMIA	16
UCSCS IN TREATMENT OF T1DM AND T2DM; A META-ANALYSIS	16
Outcome of severe hypertriglyceridemia in hospital practice. A single centre experience from Singapore	15
Sex differences in plaque characteristics of fractional flow reserve-negative non-culprit lesions after myocardial infarction	15
Reply to: “Longitudinal studies assessing retinal vascular characteristics in childhood and adolescence must account for ocular growth”	15
Loss of ADAMTS5 promotes vascular calcification via versican/integrin β1/FAK signal	15
Inflammation in COVID-19 is linked to pulmonary embolism and/or vascular tree-in-bud in hospitalized patients. The university hospital of Ioannina COVID-19 Registry, NCT05534074	15

Identification of circular RNA hsa_circ_0034621 as a novel biomarker for carotid atherosclerosis and the potential function as a regulator of NLRP3 inflammasome	15
Caveolin-1-mediated LDL transcytosis across endothelial cells in atherosclerosis	15
Diet quality, front-of-pack labeling, and lipoprotein particle profiles	15
Effect of combining evolocumab with statin on carotid intraplaque neovascularization in patients with premature coronary artery disease (EPOCH)	15
A novel homozygous variant in GPIHBP1 and familial chylomicronemia syndrome in latin America	15
The role of antiphospholipid antibodies in the onset of myocardial infarction	15
Genetic testing increases the likelihood of a diagnosis of familial hypercholesterolaemia among people referred to lipid clinics: Danish national study	15
Association between progression of coronary artery calcification and development of kidney failure with replacement therapy: Findings from KNOW-CKD study	15
Using omics data and genome editing methods to decipher GWAS loci associated with coronary artery disease	15
A novel cardiovascular-kidney-metabolic syndrome mouse model with inducible HFrEF and atherosclerosis	15
The role of antioxidant intake in weight status of children in early adolescence	15
Variant-specific LDL-cholesterol patterns and risk of atherosclerotic cardiovascular disease in heterozygous FH: Insights from the Austrian FH-Registry	14
The polycomb repressive complex 2 (PRC2) in macrophages and atherosclerosis	14
Empagliflozin prevents human aortic smooth muscle cells damage induced by cholesterol	14
Association of blood lipid profile with 20-year (2002-2022) incidence of cardiovascular disease: The ATTICA study	14
Lifestyle and rate of metabolic risk factors in Norwegian patients with a severe mental illness	14
Validation of site-less strategies and long-distance drone-based delivery and collection system to promote access to innovative treatments for patients with rare or severe dyslipidemias	14
The interplay between lipoprotein(a) and inflammatory markers in atherosclerotic cardiovascular disease (ASCVD): A focus on neutrophil-to-lymphocyte ratio (NLR)	14
Analysis of total cholesterol and its association with blood pressure, age and northern experience in men 25-54 years working on rotational shifts in the north	14
LDL drives the polarized endothelial secretion of fibronectin through syntaxin-4 and syntaxin-6	14
Docetaxel reduces hepatic lipid accumulation and atherosclerosis	14
Low dose interleukin 2 expands plasmablasts with a regulatory b cell phenotype post-MI	14
Gender disparities among contemporary patients with acute coronary syndrome: Data from CALLINICUS-hellas registry	14
Dyslipidemia and other metabolic alterations in COPD as well as cardiovascular risk in a latin American hospital.	14
Impact of circulatory microRNA-126 &122 in severity of coronary artery disease correlation with small dense LDL: A case control study	14
Lipoprotein(a) is a predictor of atherogenesis in patients with COPD	13
Genetic variation in ADAMTS13 are related to vWF levels, atrial fibrillation and cerebral ischemic events	13
Prevalence and prognostic impact of lipid goal attainment and patient adherence to lowering lipid treatment: Data from community Italian setting	13
Mature natural killer type 2 cells and experimental atherosclerosis	13
Management of hypercolesterolemic subjects at high cardiovascular risk with PCSK9 inhibitors: A “real life” experience in a lipid clinic in sicily	13
VEGF-A levels and G634c gene polymorphism as a predictor of adverse outcomes in patients with STEMI	13
Plasma concentrations of apolipoproteins and incident cardiovascular diseases in patients with type 2 diabetes	13
Treatment of vulnerable plaque using combined high-density lipoprotein and pentostatin- loaded microbubbles- mediated shock wave sonoporation therapy: Evaluation with positron emission tomography imag	13
Cardiopulmonary exercise test alterations in young smokers with obesity	13
Predictors of functional and morphological arterial wall properties in patients with increased lipoprotein (a) before and after treatment with proprotein convertase subtilisin-kexin type 9 inhibitors	13
Cardio-psycho-metabolic profile of patients with cardiovascular disease and obesity	13
Heteroplasmy of atherosclerosis-associated mitochondrial DNA mutations and its effects on respiration and viability of cybrids	13
The ceramide- and phosphatidylcholine- based coronary event risk test2 (CERT2) and cardiovascular mortality in men and women with type 2 diabetes	13
The effect of iatrogenic hypothyroidism on lipoprotein subfractions and serum paraoxonase activity in patients with differentiated thyroid cancer	13
Investigation of the antioxidant and anti-inflammatory potency of Echinacea angustifolia extract	13
LIPC-E97G gain-of-function variant protects from dyslipidemia and atherosclerosis in mice independently of the LDL receptor	13
Post-prandial analysis of fluctuations in the platelet count and platelet activity in patients with the familial chylomicronemia syndrome	13
The condition of the main arteries in patients with chronic heart failure and diabetes mellitus	12
High and low levels of serum Sirtuin6 in patients with acute ischemic stroke	12
Orbital ischemia syndrome in a patient with carotid artery dissection - Case report	12
Professor Jeremiah Stamler (1919–2022), “Father of Preventive Cardiology”	12
The use of seaweed-derived phytosterols to defeat Alzheimer's Disease	12
High lipoprotein(A) increases risk of peripheral arterial disease, abdominal aortic aneurysms, and major adverse limb events	12
Positivity of statin-associated muscle symptoms – Clinical index in a hypertensive population candidated to lipid-lowering therapy but not taking statins	12
Hospitalization features and mortality rates of very high-risk patients with dyslipidemia in Turkey	12
The patient will see you now: Patient preferences for lipid clinic reviews in a COVID era	12
Lysosomal acid lipase (LAL) deficiency alters immune cells distribution in mice and humans	12
Protective effect of niclosamide on calcification of aortic valve interstitial cells and its underlying molecular mechanism	12
Statin intolerance: What are we overlooking?	12
Arterial stiffness and glycometabolic control in older patients with type 2 diabetes	12
Nutritional approach in paediatric patients with familial hypercholesterolaemia	12
Genetic variants associated with low-density lipoprotein cholesterol and systolic blood pressure and the risk of recurrent cardiovascular disease in patients with established vascular disease	12
Ensemble machine learning for screening cardiovascular diseases in electronic health records	12
The importance of cascade screening of familial hypercholesterolemia in routine clinical practice	12
Small LDL subfractions are associated with coronary atherosclerosis	12
Epicardial adipose tissue and metabolic markers in dominican type 2 diabetics with preserved cardiac function	12
An innovative berberine formulation is able to improve bbr bioavailability and the lipid and glycemic profile in HFD-fed mice	12
Chronic kidney disease induced atherosclerosis: The regulatory role of mIR-26b	12
Diagnosis, treatment and cardiovascular outcomes in homozygous familial hypercholesterolaemia: A sex-specific analysis	12
Association of self-reported health and wellbeing indicators with a positive diagnosis for COVID-19. CARTSESIAN-CY study	12
Myeloid cannabinoid receptor CB1 deficiency limits macrophage proliferation and atherosclerosis in a sex-specific manner	12
Region-specific lipid markers of human carotid atherosclerosis plaque outcome detected by matrix-assisted laser desorption/ionization mass spectrometry imaging	12
Granzyme B+ CD4+ T cells associate with an unstable plaque phenotype in advanced human atherosclerosis	12
Protein alterations in VSMCS reveal a defective repairment capacity in thoracic aortic aneurysm associated to BAV	12
Compliance of heterozygous familial hypercholesterolemia patients: 5-years follow-up of the Russian familial hypercholesterolemia registry	12
New method of calculating low density lipoprotein cholesterol using Korea National Health and Nutrition Examination Survey (KNHANES) and its validation	12
Polymorphism of DNA repair genes (APEX1 T444G RS1130409) in obese gout patients in the male population of the trans-baikal territory in Russia	12
Response of lipoproteins to a meal tolerance test in patients with type 2 diabetes and hypertriglyceridemia	12
Associations of carotenoids, vitamin A and mortality: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study	11
Polymorphic assessment of proprotein convertase subtilisin/kexin type 9 (PCSK9) variant rs11591147 in coronary artery disease subjects from Pakistan	11
LPA genotypes and haplotypes influence lipoprotein(a) levels but not arterial wall properties, in stable post-coronary event patients with very high lipoprotein(a) levels	11
Long-term prognostic implications of hemodynamic and plaque assessment using coronary CT angiography	11
Humoral responses against HDL are linked to lipoprotein traits, atherosclerosis, inflammation and pathogenic pathways during early arthritis stages	11
Vascular wall damage in atherosclerotic cardiovascular disease; Positive effect of extracellular vesicle-based nanotherapeutics on endothelial dysfunction and its key molecular players	11
Pediatric reference values for non-fasting lipids in French-Canadian children	11
In patients with cardiovascular disease and heart failure dental state (tooth loss) may exacerbate inflammatory syndrome	11
Assessment of atherosclerotic lesions of the carotid arteries depending on the smoking index in patients with coronary artery disease	11
Double trouble: Pathogenic LDLR and SCARB1 variants in the same family	11
Association of parental obesity and body mass index in children of patients with early ischemic heart disease	11
Pemafibrate induces atheroprotection in LDLR deficient mice through hepatocyte transrepression PPARA activity	11
Increased values in total cholesterol and LDL cholesterol in “prediabetic” middle-aged and elderly adults with A1C between 5.7 and 6.4%	11
Polygenic risk for future coronary artery disease events in familial hypercholesterolemia	11
P-selectin as a modulator of fibrin clot properties in patients treated with high-dose statins	11
Dietary pattern of elderly people living in the rural area of Mortugaba (BA), Brazil	11
Frequency of variants causing familial hypercholesterolaemia (FH) and impact on LDL-C concentration in individuals of South Asian and African ancestry in the UK Biobank	11
Joint associations of peripheral artery disease and accelerometry-based physical activity with mortality: The Hispanic Community Health Study/Study of Latinos (HCHS/SOL)	11
Infectious agent as a trigger mechanism of atherosclerosis and сerebrovascular diseases	11
Alternative LDL cholesterol-lowering strategy versus high-intensity statin strategy in patients with diabetes and ASCVD: An individual patient data meta-analysis from the racing and lodestar trials	10
Comparative efficacy and safety of different RNA interference therapeutics in the management of hypertension: A systematic review and network meta-analysis of clinical trials	10
Sex differences in atherosclerosis lesions and in the response to RAS inhibition in the ApoE-/- MICE	10